Actemra IV injection 80 mg, manufactured by Chugai Pharmaceutical, contains Tocilizumab (genetically recombination). This injectable drug (YJ code: 6399421A2026) is supplied as 80mg in 4mL per bottle and is indicated for the treatment of inflammatory conditions, including rheumatoid arthritis and juvenile idiopathic arthritis.
Actemra IV injection 80 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →